Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Anticancer Research|October 3, 2018
Intraperitoneal and Systemic Chemotherapy for Patients with Gastric Cancer with Peritoneal Metastasis: A Phase II TrialMasayuki Shinkai, Motohiro Imano, Yasutaka Chiba, et al.
Scientific Reports|December 19, 2025
Intraperitoneal immune microenvironment and efficacy of intraperitoneal chemotherapy in patients with gastric cancer and peritoneal metastasisTomoya Nakanishi, Motohiro Imano, Masashi Kohda, et al.
Anticancer Research|April 9, 2013
Establishment of a novel model of peritoneal carcinomatosis of the peritoneal extension typeMotohiro Imano, Tatsuki Itoh, Takao Satou, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 17, 2014
A newly modified esophagogastrostomy with a reliable angle of His by placing a gastric tube in the lower mediastinum in laparoscopy-assisted proximal gastrectomyAtsushi Yasuda, Takushi Yasuda, Haruhiko Imamoto, et al.
Esophagus : Official Journal of the Japan Esophageal Society|April 8, 2026
Retrosternal gastric reconstruction after esophagectomy using the "waterfall" method for posterior mediastinal dead space fillingTakushi Yasuda, Osamu Shiraishi, Hiroaki Kato, et al.
Journal of Surgical Oncology|August 13, 2011
Safety of intraperitoneal administration of paclitaxel after gastrectomy with en-bloc D2 lymph node dissectionMotohiro Imano, Haruhiko Imamoto, Tatsuki Itoh, et al.
Microorganisms|April 27, 2024
Coccomyxa subellipsoidea KJ Components Enhance the Expression of Metallothioneins and Th17 Cytokines during Human T Cell ActivationToshiro Seki, Shino Ohshima, Satoko Komatsu, et al.
Clinical Nutrition ESPEN|April 20, 2026
Impact of Intensive Home Enteral Nutrition for 3 Months on Weight Loss After Oesophagectomy: A Randomised Controlled TrialOsamu Shiraishi, Yoko Hiraki, Hiroaki Kato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[A Case of Recurrent Gastric Cancer with Grade 3 Proteinuria Caused by Ramucirumab plus Paclitaxel Therapy]Yutaka Kimura, Yoichi Makari, Jota Mikami, et al.
Targeted Oncology|July 4, 2012
Peritoneal metastatic lesions of gastric cancer exhibit low expression of human epidermal growth factor receptor 2Motohiro Imano, Takao Satou, Tatsuki Itoh, et al.
Pageof 10